Equity-based Compensation - Stock Options (Details) - USD ($) $ / shares in Units, $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Number of Options | |||
Beginning balance (in shares) | 507,479 | 273,026 | 0 |
Granted (in shares) | 234,453 | 273,026 | |
Exercised (in shares) | 0 | 0 | |
Forfeited/Repurchased (in shares) | 0 | 0 | |
Ending balance (in shares) | 507,479 | 273,026 | |
Vested (in shares) | 90,666 | ||
Weighted Average Exercise Price | |||
Beginning balance (in dollars per share) | $ 9.50 | $ 0 | |
Granted (in dollars per share) | 3.97 | 9.50 | |
Exercised (in dollars per share) | $ 0 | $ 0 | |
Forfeited/Repurchased (in dollars per share) | 0 | 0 | |
Ending balance (in dollars per share) | $ 6.95 | $ 9.50 | |
Vested (in dollars per share) | $ 9.50 | ||
Weighted Average Remaining Contractual Term | 9 years 14 days | 9 years 8 months 23 days | |
Weighted Average Remaining Contractual Term, Vested | 8 years 8 months 23 days | ||
Aggregate Intrinsic Value, Outstanding | $ 0 | $ 0 | $ 0 |
Aggregate Intrinsic Value, Vested | $ 0 |
X | ||||||||||
- Definition Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Repurchases in Period No definition available.
|
X | ||||||||||
- Definition Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Repurchases in Period, Weighted Average Intrinsic Value No definition available.
|
X | ||||||||||
- Definition Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Intrinsic Value No definition available.
|
X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of options vested. No definition available.
|
X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. No definition available.
|
X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|